VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib.
Saved in:
| Title: | VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib. |
|---|---|
| Authors: | Scartozzi, M1, Bianconi, M2, Faloppi, L2, Loretelli, C3, Bittoni, A1, Del Prete, M2, Giampieri, R3, Maccaroni, E2, Nicoletti, S3, Burattini, L1, Minardi, D4, Muzzonigro, G4, Montironi, R5, Cascinu, S1 |
| Source: | British Journal of Cancer. 3/19/2013, Vol. 108 Issue 5, p1126-1132. 7p. 3 Charts, 5 Graphs. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070920 |
|---|---|
| DOI: | 10.1038/bjc.2012.501 |